Goblet cell carcinoid (adenocarcinoid, GCC) is a rare mixed neuroendocrine-epithelial tumor of the appendix. Renamed as 'goblet cell adenocarcinoma' in WHO 2019 classification. It shows both neuroendocrine differentiation (chromogranin, synaptophysin positive) and glandular/mucinous differentiation (mucin-producing goblet cells). It is significantly more aggressive than pure appendiceal carcinoid (NET) — can cause peritoneal spread, omental cake, and pseudomyxoma peritonei. However, it has better prognosis than pure colonic adenocarcinoma. Diagnosis is usually made by pathologic examination after appendectomy performed for acute appendicitis. The tumor shows concentric infiltration in the appendiceal wall — does not form intraluminal polypoid mass, making preoperative diagnosis very difficult. CT may show appendiceal wall thickening, irregular mass, or peritoneal implants. Treatment is right hemicolectomy and peritoneal staging — simple appendectomy is insufficient.
Age Range
40-75
Peak Age
58
Gender
Equal
Prevalence
Goblet cell carcinoid originates from pluripotent stem cells at the appendiceal crypt base — these cells can differentiate in both neuroendocrine and epithelial (glandular) directions. Tumor cells consist of mucin-producing goblet cells and cells containing neuroendocrine granules — this dual differentiation is confirmed immunohistochemically by co-expression of chromogranin A, synaptophysin (neuroendocrine markers) and MUC2, CK20, CDX2 (intestinal epithelial markers). The tumor infiltrates concentrically in the appendiceal wall — involves the mucosa superficially, primarily spreading along the submucosa and muscularis propria. This concentric growth pattern causes diffuse wall thickening without forming intraluminal polypoid mass — may give a 'sausage-like' appendix appearance on CT. In advanced stage, it extends beyond the serosa to spread in the peritoneal cavity — mucin-producing cells can form implants on peritoneal surfaces and pseudomyxoma peritonei. Tang classification divides into subtypes A (typical GCC), B (signet ring cell dominant), and C (poorly differentiated) based on histopathologic features — prognosis worsens from A to C.
The most characteristic imaging finding of GCC is the combination of concentric appendiceal wall thickening with peritoneal implants. The tumor spreads along the wall without forming intraluminal polypoid mass — therefore preoperative diagnosis cannot be made in most cases and appendectomy is performed with a presumed diagnosis of acute appendicitis. Presence of peritoneal implants and/or pseudomyxoma peritonei is an 'unexpected' finding — peritoneal spread detected in a patient operated for appendicitis should raise suspicion for GCC. This combination is not seen in pure carcinoid (peritoneal spread rare) or pure appendicitis (no peritoneal implants).
Concentric thickening in appendiceal wall — reflects tumor spread along submucosa and muscularis propria. Lumen may be narrowed or obstructed. Appendix diameter is increased but typically not as markedly dilated as in mucinous neoplasm.
Report Sentence
Concentric thickening is seen in the appendiceal wall, measuring ___ mm in wall thickness; tumoral involvement of the appendix should be considered in the differential diagnosis.
Nodular or plaque-like enhancing implants on peritoneal surfaces. Omental cake (thickened, enhancing omentum). Ascites may accompany. Pseudomyxoma peritonei — low-density mucinous ascites and peritoneal implants.
Report Sentence
Enhancing nodular implants on peritoneal surfaces and omental thickening are seen, consistent with peritoneal carcinomatosis; pseudomyxoma peritonei should be considered.
Moderate heterogeneous enhancement in appendiceal mass. Does not show as intense arterial enhancement as pure carcinoid. Necrotic areas do not enhance and show low density.
Report Sentence
Heterogeneous enhancement pattern is seen in the appendiceal mass with non-enhancing necrotic/mucinous areas.
Diffusion restriction in appendiceal mass — high signal on DWI, low signal on ADC map. Reflects high cellularity. Diffusion restriction may also be seen in peritoneal implants.
Report Sentence
Diffusion restriction with low ADC values is seen in the appendiceal mass; consistent with tumoral pathology showing high cellularity.
Heterogeneous signal in appendiceal mass on T2 — solid component intermediate-high signal, mucinous areas markedly hyperintense. Mixed signal pattern reflects dual histologic composition.
Report Sentence
Heterogeneous T2 signal pattern is seen in the appendiceal mass with distinguishable solid and mucinous components.
Heterogeneous echogenic mass in the appendiceal region on US. Wall layers may be disrupted. Periappendiceal fat infiltration, ascites, and peritoneal nodules may accompany.
Report Sentence
A heterogeneous echogenic mass measuring ___ mm is seen in the appendiceal region with indistinct wall layers; further imaging is recommended.
Criteria
Composed of orderly goblet cell clusters with minimal atypia. Neuroendocrine markers positive. Well differentiated. Tends to be confined to appendix.
Distinct Features
Best prognosis (5-year survival >90%). Right hemicolectomy may be curative. Peritoneal spread is rare. CT findings limited to appendiceal thickening.
Criteria
Prominent signet ring cell component (>50%). More aggressive biological behavior. Increased likelihood of peritoneal spread.
Distinct Features
Intermediate prognosis (5-year survival 40-60%). CRS + HIPEC should be considered. Peritoneal implants common on CT. Pseudomyxoma peritonei may develop.
Criteria
Adenocarcinoma component dominant, goblet cells decreased. Neuroendocrine markers may be focal or negative. High mitotic activity.
Distinct Features
Worst prognosis (5-year survival <40%). Behaves like colonic adenocarcinoma. Requires aggressive chemotherapy + surgery. Large mass and extensive peritoneal spread on CT.
Distinguishing Feature
Acute appendicitis is characterized by dilated appendix, periappendiceal fat stranding, and mural enhancement — findings limited to acute inflammatory changes. GCC shows concentric wall thickening, peritoneal implants may accompany, and failure of findings to resolve after appendicitis treatment should raise suspicion.
Distinguishing Feature
Pure appendiceal carcinoid presents as a small (<2 cm), well-defined, homogeneous submucosal nodule with intense arterial enhancement. GCC is larger, heterogeneous, shows concentric growth pattern, and can cause peritoneal spread — peritoneal spread is very rare in pure carcinoid.
Distinguishing Feature
Mucinous neoplasm is characterized by low-density luminal dilation, wall calcification, and mucinous ascites — solid component is minimal or absent. GCC forms solid/mixed mass, shows wall thickening rather than marked luminal dilation, and enhances heterogeneously. Both can cause pseudomyxoma peritonei but solid peritoneal implants predominate in GCC.
Distinguishing Feature
Colorectal adenocarcinoma usually shows apple-core mass in colon/rectum wall and lymphadenopathy — not specific to appendix. GCC is appendix-specific and shows concentric growth pattern with dual immunohistochemical profile (neuroendocrine + epithelial). Definitive differentiation is made by pathologic examination.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
6-monthTreatment of goblet cell carcinoid depends on Tang classification and stage. Even if initial appendectomy has been performed, completion right hemicolectomy is recommended in all cases — because risk of local lymph node metastasis is high. In presence of peritoneal spread, CRS (cytoreductive surgery) + HIPEC (hyperthermic intraperitoneal chemotherapy) is considered — especially in Tang B and C. Systemic chemotherapy (5-FU-based regimens) is administered in advanced stage. Postoperative follow-up: CT abdomen-pelvis and tumor markers (chromogranin A, CEA) every 6 months for at least 5 years. Prognosis varies by Tang classification: Tang A >90%, Tang B 40-60%, Tang C <40% five-year survival. As a radiologist, although preoperative diagnosis is difficult, GCC should be considered in the differential when peritoneal implants or unexpected appendiceal mass are detected in a patient operated for appendicitis, and pathologic examination should be recommended.
Goblet cell carcinoid is a moderately aggressive tumor. Right hemicolectomy + peritoneal staging is standard treatment. In presence of peritoneal spread, CRS (cytoreductive surgery) + HIPEC (hyperthermic intraperitoneal chemotherapy) is considered. 5-year survival ranges from 60-100% depending on Tang classification.